Document is current
Any future updates will be listed below
-
Authors
Morikawa, Kei
Takashima, Yuta
Oki, Masahide
Tsuzuku, Akifumi
Murakami, Shuji
Minami, Daisuke
Fujii, Shinji
Shinagawa, Naofumi
Asano, Fumihiro
Nakamura, Seiji
Sato, Yoshiharu
Ueda, Yumi
Suzuki, Fumihiko
Yokose, Tomoyuki
Tanabe, Kenichiro
Mineshita, Masamichi
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 29 July 2025
First Online: 9 October 2025
Declarations
:
: ・The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of St. Marianna University School of Medicine (approval number 5532).・Written informed consent was obtained from all participants prior to study initiation.・The study registered in the UMIN Registry (UMIN000047215) on March 18, 2022. An independent data-monitoring committee reviewed the clinical data.・Animal Studies: N/A.
: All authors have contributed significantly, and that all authors are in agreement with the content of the manuscript.
: Kei Morikawa reports financial support was provided by DNA Chip Research Inc, and received lecture fees as honoraria from Eli-Lilly, Chugai Pharmaceutical, Takeda Pharmaceutical, AstraZeneca K.K., Daiichi Sankyo, MSD, Nippon Boehringer Ingelheim Co., Ltd., and Bristol-Myers Squibb Japan. Yoshiharu Sato, Seiji Nakamura, Yumi Ueda, Fumihiko Suzuki reports a relationship with DNA Chip Research Inc that includes: employment and equity or stocks
